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ABSTRACT 
Pregnancy complications, such as preeclampsia are associated with impaired 
trophoblast invasion. Although placental development depends on careful 
coordination of trophoblast proliferation and apoptosis, little is known about the 
equilibrium that exists between these two key processes that synchronise trophoblast 
invasion. The aim of this study was to determine whether an imbalance exists 
between trophoblast apoptosis (M30), and proliferation (Ki-67) in term placental beds 
of pre-eclamptic and normal pregnancies. 
This retrospective study was conducted on true placental bed biopsies obtained from 
12 normotensive and 12 hypertensive pregnant women at the Obstetric Unit of King 
Edward VIII Hospital, Durban, South Africa. Routine histopathology assessment of 
the biopsies was performed and using immunocytochemistry techniques, serial 
sections were immunolabelled with a Rabbit Anti-Human Ki67 antibody, monoclonal 
Mouse Anti-Human Cytokeratin 18 and its neo-epitope, a monoclonal M30, 
Cytodeath antibody. 
Histologically, two populations of invasive extravillous trophoblast were identifiable 
within the myometrium in the normotensive group viz. interstitial and intramural 
trophoblast cells embedded within the spiral artery. ln the preeclamptic group, the 
spiral arterioles did not demonstrate physiological conversion and were further 
compromised by a reduced lumen with endothelial vacuolation and smooth muscle 
hyperplasia. 
V 
The immunoexpression of anti-Ki67 for all trophoblast cell sub populations within 
the myometrium were non-reactive for both study groups. However, smooth muscle 
cells of the small caliber microvasculature signify a moderate degree of proliferation 
in both groups. Morphometric image analysis of the wall of the spiral artery in the 





and preeclamptic groups respectively (p<0.0001). Additionally, 
immunoexpression of anti-CK 18 indicated intramural trophoblast invasion in the 
spiral artery of normotensive group was elevated compared to the pre-eclamptic 
group (13 ± 5% vs 0% respectively; p<0.0001). Comparative analyses of M30 
distribution on corresponding serial sections were 2.5 ± 0.7% vs 0% in the 
normotensive and pre-eclamptic groups respectively (p<0.000 I). The mean field area 
of the interstitial trophoblast invasion in the preeclamptic group was 2.87 ± 0.5% 
compared to I 0.79 ± 4.2% in the normotensive group (0.000002). However the serial 
sections stained with M30 showed elevation of apoptotic invasive interstial 
trophoblast in the preeclamptic group compared to the normotensive group ( 1.9 ± 8% 
VS 0.8 ± 0.3%; p=0.00J). 
In conclusion, the expression pattern of Ki67 antigen 10 this study suggests that 
differentiation of invasive trophoblasts at term is coordinated with exit from the cell 
cycle. Increased apoptosis of interstitial trophoblast cells may be implicated in the 
aetiology of shallow invasion of trophoblasts in pre-eclampsia. The balance between 
trophoblast apoptosis and proliferation, in favour of increased apoptosis may 
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The term apoptosis comes from the ancient Greek word meaning "the falling of petals 
from a flower or of leaves from a tree in autumn". Apoptosis is an evolutionarily 
conserved, genetically regulated active process characterised by profound distinct 
changes in the cellular architecture leading to self destruction of cells (Kerr et al., 
1972). 
It is the process of programmed cell death or cell suicide and is a normal component 
of the development and health of multicellular organisms (Kerr et al., 1972). Cells 
undergo apoptosis as a form of creating a balance between the withdrawal of positive 
signals needed for continued cell survival and the receipt of negative signals 
threatening the cell. 
There are two ways in which this process occurs: 
a. death by injury - as can be seen in cases of trauma and mechanical damage.
b. death by "suicide" - a process in which cells play an active role in their own
death (Kerr et al., 1972).
A number of distinctive biochemical and morphological alterations occur within the 
cell undergoing apoptosis. 
In trophoblast cells, apoptosis occurs throughout pregnancy and is an essential 
counterbalance to cellular proliferation. A family of proteins known as caspases are 
activated to cleave cellular substrates required for the normal functioning of the cells 
and nuclear proteins (Strasser et al., 2000). 
This causes morphological changes to occur in the cell, as is depicted by time-lapse 
microscopy images of a trophoblast cell undergoing apoptosis (Fig. 1 A-D). 
Following the cleavage of lamins and actin filaments, the cytoplasm shrinks (Fig I A). 
This is followed by nuclear condensation due to the breakdown of chromatin and 
nuclear structural proteins, the nuclei take on a "horse-shoe" like appearance (Fig 
1 B). Cells continue to shrink, packaging themselves into a form that allows for easy 
clearance by macrophages (Fig IC). Apoptotic cells often undergo plasma membrane 
changes that trigger the macrophage response. One such change is the translocation 
of phosphatidylserine from the inner membrane of the cell to the outer surface. 
Blebbing of the membrane may be observed (Fig ID) often towards the end of the 
apoptotic cycle. Small vesicles called apoptotic bodies may also sometimes be noted 
(Fig ID). 
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Fig I: Real-time microscopy images of trophoblast cells undergoing 
apoptosis in-vitro 
A: Cytoplasm shrinkage B: Nuclear condensation 
C: Cell Shrinkage D: Presence of apoptotic bodies 
(Reproductive and Cardiovascular Disease Research Group, 2005) 
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1.1 Mechanisms of Apoptosis 
In recent years, the molecular machinery responsible for apoptosis has been 
elucidated revealing a family of intracellular proteases which are directly or indirectly 
responsible for the morphological and biochemical changes that characterise this 
phenomenon (Barret et al., 200 I; Reed et al., 2000). 
There are two major pathways that induce apoptosis (Fig 2): 
(a) extrinsic pathway
(b) intrinsic mitochondrial pathway (Strasser et a/.,2000)
Induction of apoptosis may occur by external or internal stimuli. The sensitivity of 
cells to these stimuli may vary depending on a number of factors such as the 
expression of pro- and anti-apoptotic proteins, the severity of the stimulus and the 
stage of the cell cycle. Some of the major stimuli that can induce apoptosis include 
(Fig 3): 
a) Binding of death inducing ligands to cell surface receptors (I).
b) Cellular stress such as exposure to radiation (2) or chemicals
c) Viral infection (3) initiates apoptosis via intrinsic signals.
d) Cytotoxic T-lymphocytes induction by granzyme in the presence of
damaged or virus infected cells (4).
e) Growth factor deprivation or oxidative stress. Apoptosis initiated by 
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Fig 2: Two major apoptotic pathways are illustrated: intrinsic and extrinsic activated via death 
receptor activation and the other by stress-inducing stimuli, respectively. Triggering of cell 
surface death receptors of the tumour necrosis facror (TNF) receptor superfamily (CD95 and 
TNF-related apoptosis-inducing ligand (TRAIL)-R 1 /-R2), results in rapid activation of the 
initiator caspase 8 after its recruitment to a trimeri ed receptor-ligand complex (DISC) 
through the adaptor molecule Fas-associated death domain protein (FADD). In the intrinsic 
pathway, stress-induced apoptosis results in perturbation of mitochondria and the ensuing 
release cytochrome c from the inter-mitochondrial membrane space. The release of 
cytochrome c is regulated in part by Bc12 family members, with anti-apoptotic (Bcl2/ Bcl­
XJMcl I) and pro-apoptotic (Bax, Bak and tBid) member inhibiting or promoting the release, 
respectively. Cytochrome c then binds to apoptotic protease-activating factor I (Apafl ), 
resulting in the formation of the Apaf l-caspase 9 apoptosome complex and activation of the 
initiator caspase 9. This then activates the effector caspases 3, 6 and 7, which are responsible 
for the cleavage of important cellular substrates resulting in the classical biochemical and 





Fig 3: Schematic illustration of intrinsic and extrinsic stimuli that induce apoptosis 
(Reproductive and Cardiovascular Disease Research Group, 2005): 
Binding of death inducing ligands to cell surface receptors 
2 Cellular stress such as exposure to radiation or chemicals 
3 Viral infection initiates apoptosis via intrinsic signals. 
4 Cytotoxic T-lymphocytes induction by granzyme in the presence of damaged or virus 
infected cells. 
5 Growth factor deprivation or oxidative stress, apoptosis initiated by intrinsic signals 
generally involves the mitochondria. 
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1.1.1. Extrinsic Factors 
1.1.1.1 Death receptors 
Death receptors (DR) are cell surface receptors that belong to the tumor necrosis 
factor gene (TNF) family. These receptors signal specific ligands to induce 
apoptosis. This mechanism of apoptosis induction is very rapid as the caspase 
cascade is activated within seconds of ligand binding (Krammer et al, 2000). The 
death receptors are CD95 (or Fas), TNF receptor- I (TNFR I) and the TNF-related 
apoptosis inducing ligand (TRAIL) receptors DR4 and DRS (Ashkenazi et al., 2002). 
1.1.1.2. Signaling by CD95 / Fas 
The ligand for CD95 (CD95L or FasL) is a trimer that on association with the 
receptor promotes receptor-trimerisation which in turn results in intracellular 
clustering of parts of the receptor called death domains (DD) (Fig 4) (Krammer et al., 
2000). This allows an adapter protein called Fas-associated death domain (FADD) to 
associate with the receptor through an interaction between homologous death 
domains on the receptor and on FADD. FADD also contains a death effector domain 
(OED). 
The death effector domain allows binding of pro-caspase 8 to the CD95-FADD 
complex. Pro-caspase 8 (also known as FLICE) associates with FADD through its 
own death effector domain, and upon recruitment by FADD is immediately cleaved 
to produce caspase 8. 
7 
This then triggers activation of execution caspases such as caspase 9 that cleave 
multiple cellular death substrates resulting in inevitable apoptosis (Krammer et al., 
2000). 
8 




Fig 4: Activation of apoptosis through CD95 / Fas Receptor trimerisation of CD95 
with death domains allows FADD to associate with the death domains. FADD also 
houses OED which allows binding of pro-caspase 8 to the CD 95-FADD complex. 
FADD is immediately cleaved to produce Caspase 8. This in turn triggers activation 
of execution caspases resulting in inevitable apoptosis (Reproductive and 

















Fig 5: TNF receptor signaling (Reproductive and Cardiovascular Disease 
Research Group, 2005) 
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1.1.1.3 Induction of apoptosis by TNFoc Related Apoptosis-lnducing 
Ligand (TRAIL) 
Binding of TRAIL to its receptors DR4 or DR5 triggers rapid apoptosis in many 
cells. The DR4 and DR5 receptors contain death domains in their intracellular 
domain, but as yet no adaptor molecule (such as FADD or TRADD) has been 
identified that associates with the receptor to initiate apoptosis (Su Ii man et al., 200 I )  
(Fig 5). 
1.1.2 Intrinsic Factors 
1.1.2.1 Role of Mitochondria in Apoptosis 
Mitochondria have the ability to promote apoptosis through the release of cytochrome 
C (Liu et al., 1996). Mitochondrial permeability and release of cytochrome C is 
regulated by a family of proteins called Bcl-2. There are both anti-apoptotic and pro­
apoptotic Bcl-2 proteins found in the mitochondria (Chittenden et al., 1995). The 
pro-apoptotic proteins, Bad, Bid, Bax and Bim, reside in the cytosol but translocate to 
mitochondria following death signaling, where they promote the release of 
cytochrome C. Anti-apoptotic proteins Bcl-2 and Bcl-xL reside in the outer 
mitochondrial wall and inhibit cytochrome C release (Kroemer et al., 1997). Since 
Bax, and other Bcl-2 proteins, show structural similarities with pore-forming 
proteins, it has been suggested that Bax can form a transmembrane pore across the 
outer mitochondrial membrane, leading to loss of membrane potential and efflux of 
cytochrome C and AIF (apoptosis inducing factor) (Susin et al., I 999). 
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Bcl-2 and Bel-XL may prevent this pore formation (Gross et al., 1999). 
Heterodimerisation of Bax or Bad with Bcl-2 or Bel-XL is thought to inhibit their 
protective effects (Fig 6). 
In addition, Bax and Bad can also promote the formation of the large diameter PT 
pore (Green and Kroemer, 2004), with subsequent loss of cytochrome C and initiation 









Fig 6: Role of Mitochondria in Apoptosis; Pro- and Anti - apoptotic Bcl-2 
proteins regulate the release of cytochrome c in the mitochondria. Proteins 
either translocate from the cytosol to the mitochondria following death 
signalling or forming a transmembrane pore leading to the loss of membrane 




Caspases (cysteinyl aspartate-specific proteases), a group of cysteine proteases, are 
one of the main effectors of apoptosis. These enzymes cleave specific proteins at 
aspartate residues. Two main pathways activate Caspases: the death receptor 
pathway and the mitochondrial pathway (Salvesen and Dixit, 1997). 
The caspases exist within the cell as inactive pro-forms or zymogens. These 
zymogens can be cleaved to form active enzymes following the induction of 
apoptosis. At least 14 caspase isoforms have been identified which are broadly 
categorised into initiators, effectors and inflammatory caspases. Induction of 
apoptosis activates initiator (caspase 8 or 10) and effector caspases (caspase 3 or 6) in 
cascade. This cascade results in the cleavage of the key cellular proteins that leads to 
the typical morphological changes observed in cells undergoing apoptosis. The 
mitochondria are also key regulators of the caspase cascade and apoptosis. Release 
of cytochrome C from mitochondria can lead to the activation of caspase 9, and then 
of caspase 3 (Shi, 2002). This effect is mediated through the formation of an 
apoptosome (Fig 7), a multi-protein complex consisting of cytochrome C, Apaf-1, 
pro-caspase 9 and ATP (Waterhouse et al., 2002; Fig 8). 
14 




Fig 7: Caspase Activation (Reproductive and Cardiovascular Disease 
Research Group, 2005) 
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2.1 Preeclampsia (PE) 
Preeclampsia, a multisystem disorder unique to pregnancy is characterised clinically 
by increased blood pressure accompanied by proteinuria, edema, or both (Perloff, 
1998). 
Either of the following criteria suffice for the diagnosis of hypertension in this 
situation: (I) systolic blood pressure increases of 30mm Hg or greater or (2) diastolic 
blood pressure increases of 15mm Hg or greater from early values (average of values 
before 20 weeks' gestation). If prior blood pressure is not known, readings of 140/90 
mm Hg or greater after 20 weeks' gestation are considered sufficiently elevated to 
satisfy the blood pressure criteria of preeclampsia. Note, however, that many young 
pregnant women will show blood pressure increases required for the diagnosis of 
preeclampsia without their pressure increasing to 140/90 mm Hg (Report of the 
National High Blood Pressure Education Program Working Group on High Blood 
Pressure in Pregnancy, 2000). 
Proteinuria is defined as the excretion of 0.3 g or greater in a 24-hour specimen 
(Davey et al., 1988). This will usually correlate with 30 mg/di ("I+ dipstick") or 
greater in a random urine determination. Proteinuria usually presents as a late clinical 
sign in the course of preeclampsia; although it is nonspecific, its appearance greatly 
bolsters the diagnosis of preeclampsia (Higgins and Swiet, 200 I) 
18 
Women with hypertension can be classified into four main categories: 
• Gestational hypertension. This is hypertension occurring for the first time
after 20th week of pregnancy.
• Preeclampsia is defined as hypertension in pregnancy asssociated with
proteinuria of> 0.3 g/day in 24-hour urine collection.
• Chronic or preexisting hypertension which pre-dates preeclampsia or is
diagnosed prior to the 20
1h 
week of gestation
• Superimposed preeclampsia. This is high blood pressure and proteinuria
superimposed on the preexisting hypertension or renal disease
All women with hypertensive disorders in pregnancies should be assessed 6 - I 2 
weeks following delivery, in order to reclassify their condition. In gestational 
hypertension and preeclampsia all abnormalities should have returned to pre­
pregnancy levels (Moodley, personal communication). 
2.1.1 Epidemiology of Preeclampsia 
At risk are mainly primigravidae and women with renal diseases, diabetes mellitus, 
pre-existing hypertension and microvascular disorders (Ness et al., 2003). Eighty­
five percent of preeclamptic cases occur in primigravid women with seldom re­
occurrence in subsequent pregnancies (Robillard et al., 1994). However, with a 
change in partner, the risk with multiparous women increases. If there is a family 
history of hypertension there is a risk of PE in a first-degree relative (Saftlas et al., 
2003). Preeclampsia is more common in black women compared to other racial 
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groups. This is due to the higher prevalence of underlying chronic hypertension 
(Klonoff-Cohen et al., 1989). Worldwide, preeclampsia affects women mostly at the 
two extremes of reproductive age ( < l 8yrs or >35yrs) (Fisher et al., 1981 ). 
2.1.2 Risk Factors for Preeclampsia 
A recent review suggests that a previous history of preeclampsia, multiple pregnancy, 
nulliparity, pre-existing diabetes, high BMI before pregnancy, maternal age >40 
years, renal disease, hypertension, >IO years since previous pregnancy and presence 
of antiphospholipid antibodies all increase a woman's risk of developing 
preeclampsia (Duckitt and Harrington, 2005). Increases in risk of more than nine 
fold, sevenfold and threefold, respectively, were documented for antiphospholipid 
antibodies, previous history of preeclampsia and diabetes. 
Other risk factors for preeclampsia are insulin resistance in concert with obesity and 
thrombophilia (Walker, 2000; Wolf et al., 2002; Kupferminc et al., 1999). In 
developing countries, protein-calorie undernutrition has been identified as an 
important risk factor (Brewer, 1976). 
2.1.3 Genetic Risk factors 
The precise role of genetic factors in the development of preeclampsia is unclear, and 
no specific contributory gene has been identified. The inheritance pattern of the 
disease has been described as Mendelian (autosomal recessive and autosomal 
dominant with incomplete penetrance), polygenic/multifactorial and mitochondrial 
(Ward et al., 1993). 
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Studies have indicated an association between preeclampsia and polymorphisms of 
genes that control blood pressure, coagulation or oxygen-free-radical metabolism -
such as renin, angiotensinogen, endothelial nitric oxide synthase, factor V Leiden, 
methyltetrahydrofolate or lipoprotein lipase (Villar and Belizan, 2000; Amgrimsson 
et al., 1997; Dizon-Townson et al., 1996; Sohda et al., I 997). Linkage analysis has 
identified three potential loci linked to susceptibility to preeclampsia: 2p 13, 2p25 and 
9p 13 (Laivuori et al., 2003; Lachmeijer et al., 200 I; Moses et al., 2000). A fourth 
locus for preeclampsia was subsequently identified on 10q22. Maximal allele sharing 
between pre-eclamptic sisters at this locus was observed for maternal-derived but not 
paternal-derived alleles, indicating matrilineal inheritance (Oudejans et al., 2004). 
In a large study by the British Genetics of Preeclampsia Consortium, 657 women 
affected by preeclampsia and their families were genotyped at sites of 28 single­
nucleotide polymorphisms in several genes, including those involved in angiotensin 
activity and oxidative stress (GOPEC Consortium, 2005). None of the genetic 
variants tested were found to confer a high risk of disease development, indicating 
that alterations of angiotensin activity and oxidative stress are not prime causes of 
preeclampsia. 
2.1.4 Pathophysiology of Preeclampsia 
The cause of PE remains unknown but has been associated with placental dysfunction 
which initiates systemic vasospasm, ischemia and thrombosis that eventually 
damages maternal organs (Brown et al., 1991 ). There is maternal endothelial cell 
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damage due to the release of substances from a poorly perfused placenta (Brown et 
al., 1991 ). This creates an increased responsiveness to a variety of endogenous 
substances. Renal necrosis leads to decreased glomerular filtration and there is an 
increase in renal blood flow as opposed to normal pregnancy. There is also an 
increase in urinary protein excretion. Liver injury from hepatocellular necrosis leads 
to elevation of liver enzymes with subsequent abdominal pain (Gallery and Brown, 
1987). Cardiovascular and hematologic manifestations include increased cardiac 
output, lower intravascular volume and thrombocytopenia. Neurologic dysfunction 
with other signs defines eclampsia (Smith, 1993). 
Eclampsia is the most serious complication of hypertensive disorders of pregnancy. 
It ranges from 0.5% to 0.8% of pregnancies (Sahin, 2003). Seizures, cerebral 
hemorrhage, edema vasospasm and thrombosis can al I occur. Cerebral hemorrhage is 
the leading cause of maternal death from eclampsia (Royburt et al., 1991 ). 
When vasospasm affects the uteroplacental bed, the fetus becomes growth restricted 
accompanied by an increased risk of stillbirth and neonatal death. The incidence of 
intrauterine fetal growth restriction related to PE ranges from 30-80% (Helewa et al., 
1997). 
There is increased cardiac output which is the fundamental haemodynamic 
derangement in PE (Easterling et al., 1990). The capillary beds are damaged by 
exposure to elevated pressures and flow. This is due to maximal compensatory 
vasodilation which is caused by hyperperfusion. Endothelial cells lose their normal 
response to physiological changes and demonstrate new responses, leading ultimately 
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to diffuse vasospasm, alteration in coagulability, and increased permeability (de 
Groot et al., 1993). Blood concentrations of a number of substances manufactured or 
regulated by endothelial cells have been found to be altered suggesting that these 
substances may mediate the observed pathophysiological changes. Other 
pathological features of preeclampsia are acute atherosis and persistent intraluminal 
endovascular trophoblast cells. Acute atherosis is characterised by fibrinoid necrosis 
of the vessel wall with a perivascular mononuclear cell infiltrate and lipid-laden 
macrophages. Acute atherosis labels for lipoprotein-a, which is thrombogenic and 
atherogenic, and it is not surprising therefore that thrombosis is often seen within 
these uteroplacental arteries (Fig 9) (Meekins et al., 1994) 
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Fig 9: Pathophysiology of Preeclampsia (Medscape, 2005) 
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The placenta has been suggested to be the primary cause of PE, since delivery of the 
placenta resolves the signs and symptoms of PE (de Groot et al., 1993). In addition, 
women with molar pregnancies, which are characterised by placental tissue in the 
absence of a fetus frequently, develop PE (Slattery et al., 1993). From this it is 
concluded that placental dysfunction may possibly be the primary trigger responsible 
for both the pathophysiology and pathogenesis of preeclampsia. Supporting the 
pathogenic role of placental ischaemia, preeclampsia is more common in conditions 
where placental oxygen demand is increased (as in multiple pregnancies) or those 
with decreased oxygen transfer due to preexisting vascular alterations. The latter 
would explain the high incidence of preeclampsia in primigravidas whose uterine 
vasculature is less developed than those of multiparas or women with microvascular 
alterations secondary to chronic hypertension or diabetes (Redman, 1991 ). 
For a pregnancy to proceed normally, the early blastocyst must adhere to and invade 
the uterine endometrium so that maternal blood can effectively bathe the placental 
cotyledons (Red-Horse et al., 2004). Trophoblast cells derived from the basal plate 
and the tips of the anchoring villi infiltrate into the decidua and inner myometrium in 
a timed sequence (Pijnenborg et al, 1980). Two populations of invasive extravillous 
trophoblasts have been identified viz. interstitial and endovascular trophoblasts. 
Interstitial trophoblasts invade the decidual stroma and reach the myometrium. At 
the end of their invasion path, these cells fuse to form multi nuclear giant cells (Lyall, 
2002). 
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In another pathway, the trophoblast cell migrates into the lumen of the spiral arteries, 
invades, and replaces the endothelium, internal elastic lamina, and musculoelastic 
media of these arteries. The vascular change extends from the intervillous space to 
the inner third of the myometrium (Robertson et al., 1986; Pijnenborg, 1996). This 
process is usually completed by 20 weeks of gestation. These muscular arteries are 
converted to a low resistance high capacitance system, with a 4 to 6 fold increase in 
arterial diameter, hence meeting the oxygen and nutrient demands of the growing 
foetus. This transformation of the artery by the trophoblast cell is called a 
"physiological change". The time and sequence of events in the remodelling of these 
arteries is portrayed in Figure 10 (Brosens et al., 1972). 
In preeclampsia, early in pregnancy, the migration of trophoblast cells in the maternal 
tissues is compromised resulting in a lack of physiological vascular changes. 
Placental derangement begins with the impaired extravillous trophoblast invasion of 
the spiral arteries with the consequent failure of vascular dilation and remodeling and 
hence placental ischaemia (Brosens er al., 1972; Ghidini et al., 1997). Intraluminal 
migration of the trophoblast cell in spiral arteries is limited to the decidua (Khong et 
al., 1986; Pijnenborg et al., 1991; Zuspan, 1988; Redman, 1991 ). The arteries fail to 
dilate adequately and the spiral arteries retain responsiveness to vasoconstrictors. 
Arteries dilate to only 40% of the diameter occurring in normal pregnancy with a 
resultant underperfusion of the developing placenta (Roberts and Redman, 1993). 
Consequently, abnormal trophoblast invasion, with resultant lower intervillous blood 
flow would place the fetus at risk of oxygen and nutrient deprivation (McParland et 
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al., 1988; Kingdom et al., 1997). From this, it is plausible to hypothesise that up­
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Fig I 0: Schematic illustration of remodelling of Spiral Artery by Trophoblast cells 
(Reproductive and Cardiovascular Disease Research Group, 2005) 
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2.2 Apoptosis in Preeclampsia 
Normal placental development involves constant tissue remodeling characterised by 
the functional loss of trophoblast cells by apoptosis. After proliferation and 
differentiation into specific cell subtypes, aging trophoblast cells are selectively 
removed and replaced by a younger population of trophoblasts without affecting 
neighboring cells (Mayhew, 2001 ). In complicated pregnancies such as 
preeclarnpsia, a greater incidence of trophoblast apoptosis has been observed (Allaire 
et al., 2000), suggesting that alterations in the regulation of trophoblast apoptosis may 
contribute to the pathophysiology of this disease (Smith et al, 2002). 
Cells undergoing apoptosis are quickly removed by phagocytosis. Macrophages 
present at the maternal-fetal interface quickly remove apoptotic cells to promote 
trophoblast survival and facilitate invasion and transformation of the spiral arteries 
(Mor and Abrahams, 2003). In placentas from complicated pregnancies, shallow 
trophoblast invasion and inefficient spiral artery transformation have been observed 
which may be partly due to the distribution and activation state of infiltrating 
macrophages (Brosens et al., 1972). The increase in trophoblast apoptosis may be 
attributed to placental oxidative stress which may be triggered by hypoxia (Kilani et 
al., 2003). 
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3.0 Normal Cell cycle 
Cell proliferation is a biological process of fundamental importance controlled by 
highly coordinated mechanisms (Schulter et al., 1993). Apotosis is a process of the 
normal cell cycle events. The cell cycle can be defined as an ordered set of events 
culminating in cell growth and division into two identical daughter cells. In normal 
cells this complex process is initiated only in the presence of a mitogenic stimulus 
(Norbury and Nurse, 1992). 
The cell cycle consists of several phases (Figure I I). In the first phase (GI) the cell 
grows and becomes larger. When a cell has reached a certain size it enters the next 
phase (S), in which DNA-synthesis takes place. The cell duplicates its hereditary 
material (DNA-replication) and a copy of each chromosome is formed. During the 
next phase (G2) the cell checks that DNA-replication is completed and prepares for 
cell division. The chromosomes are separated (mitosis, M) and the cell divides into 
two daughter cells. Through this mechanism the daughter cells receive identical 
chromosome set ups. After division, the cells are back in GI and the cell cycle is 
completed (Norbury and Nurse, I 992). 
Although placental development depends on careful coordination of trophoblast 
proliferation and differentiation, little is known about the mitotic regulators that are 
the key to synchronizing these events. Alterations in trophoblast expression of cell 
cycle markers may provide the basis for understanding factors that lead to abnormal 













Fig 11: Cell cycle (From Learning Lab) [online image] Available at 




The Ki67 protein was originally identified as an antigen which was recognised by the 
prototype antibody Ki67 (Gerdes et al., 1983). The name was derived from the city 
of origin, Kiel, and the number of original clones in a 96-well plate. The unique 
feature found in the Ki67 primary structure is the occurrence of 16 repeated elements, 
each with a size of approximately 122 amino acid residues (Scholzen et al., 1997). 
There is a highly conserved region present within the repetitive elements called the 
Ki67 motif which houses the epitope recognised by the Ki67 antibody (Scholzen and 
Gerdes, 2000). 
In contrast to many other cell cycle-associated proteins the Ki-67 antigen is 
consistently absent in quiescent cells and is not detectable during DNA repair 
processes (Hall et al., 1993). It is a constituent of compact chromatin (Kreitz et al., 
2000) and is vital for cell proliferation, since removal of Ki67 protein using antisense 
nucleotides prevents cell proliferation (Schluter et al., 1993). Recent studies have 
showed that the C terminus of Ki67 interacts with heterochromatin protein I family 
and potentially plays a role in higher-order chromatin organization (Schlozen et al., 
2002). These data suggest that Ki67 protein is involved in the protein interaction 
network that drives cell division cycles. It is evident that Ki67 can be used as a tool 
to estimate the growth fraction of any human cell population as it has been detected 
during all active phases of the cell cycle (Sholzen and Gerdes, 2000). This stringent 
feature has made Ki67 a popular prognostic and diagnostic tool (Brown et al., 2002). 
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The topographical distribution of the Ki-67 antigen is cell cycle dependent (Braun et 
al., 1988; Guillaud et al., 1989; du Manoir et al., 1991). In the GI phase the Ki-67 
antigen is predominantly localised in the perinucleolar region, whilst in the later 
phases of the cell cycle the antigen is also detected throughout the nuclear interior, 
being predominantly localised in the nuclear matrix (Verheijen et al., 1989a). In the 
S-phase, Ki-67 immunostaining was restricted to the nucleoli (Kill et al., 1996) and in
the nucleoplasm (Braun et al., 1988). During the G2-phase cells Ki67 was detected 
in the nucleus (du Manoir et al., 1991) foci in addition to a diffuse neoplasm 
distribution (Braun et al., 1988). 
In mitosis, there is a prominent redistribution of Ki-67 antigen. During prophase the 
Ki67 protein is reorganised and is detectable as a fine meshwork associated with 
condensing chromatin (Verheijen er al., 1989b). In metaphase, a bright Ki67 antigen 
staining is visible covering the surface of the individual chromosome (Yerheijen et 
al., 1989b). During anaphase and telophase the Ki67 protein has been detected 
distributed diffusely in the cytoplasm (Braun et al., 1988). The biological half-life of 
Ki67 has been estimated to be one hour as the immunostaining of Ki-67 rapidly 
decreases towards the end of mitosis (Bruno and Darzynkiewics, 1992). 
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3.2 Cytokeratin 18 (CK18) 
Cytokeratins (CK) are a family of intermediate filament proteins comprising an 
essential component of the cytoskeleton of epithelial cells (Anderton et al., 1981 ). 
There are over 20 different polypeptides of CK expressed by human epithelia that 
have been defined on the basis of their molecular weights and isoelectric points (Moll 
et al., 1982a). Cytokeratins are expressed in a tissue-specific and a differentiation­
dependent manner and are present in both keratinizing tissue and non-keratinizing 
tissue. Biochemically, cytokeratins are usually expressed in pairs comprising a type I 
(acidic polypeptide, CK9-20) and a type II (basic polypeptides, CK 1-8) cytokeratins 
(Eichner et al., 1986). At present, cytokeratins act as resilient yet pliable scaffolds 
that endow epithelial cells with the ability to sustain mechanical and non-mechanical 
stresses (Coulombe et al., 2002). Cytokeratins play a critical role in differentiation 
and tissue specialization and function to maintain the overall structural integrity of 
epithelial cells (Moll et al., 1982a). Together with actin microfilaments and 
microtubules. keratin filaments make up the cytoskeletons of vertebrate epithelial 
cells, forming alpha-helical coiled-coil dimers which associate laterally, and end-to­
end to form 10-nm diameter filaments (Coulombe el al., 2002). 
Cytokeratin 18 has a widespread distribution and is co-expressed with cytokeratin 8 
(CK8/l 8). It i� an acidic keratin and is expressed in simple nonstratified, ductular 
and pseudostratified epithelia (Leers et al., 1999). 
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These two cytokeratins are the first intermediate filaments to be expressed during 
mammalian development being associated with the differentiation to the 
trophectodermal layer of the blastocyst (Leers et al., 1999). 
Trophoblasts are of epithelial origin, and CK 18 is a component of their cytoskeleton. 
Recently, cytokeratins have been observed to aggregate in apoptotic cells, this is 
mediated by hyperphosphorylation (Liao and Omary, 1996). Apart from 
hyperphosphorylation, CK 18 undergoes a dramatic re-organization as it is cleaved by 
caspases 3 and 7, generating an apoptosis-specific neo-epitope, which is a specific 
formalin-resistant caspase cleavage site (Caul in et al., 1997). This site is not present 
in normal cytokeratin 18 or cleavage sites not related to caspase proteolytic cleavage. 
This speci fie proteolytic cleavage occurs before the disrnption of membrane 
asymmetry and DNA strand breaks (Leers et al., 1999). The release of this neo­
epitope occurs early in the apoptotic cascade and is recognised by the M30 antibody. 
This monoclonal antibody has been used successfully for analyzing apoptosis 
especially m epithelial cells, which placental villious trophoblasts are one type 
(Kadyrov et al., 2001 ). The M30 antibody identifies early changes in the 
cytoskeleton related to action of caspases in apoptosis 
Studies have suggested that the detection of cleaved CK 18 could be a promising 
specific assay for apoptosis identification (Kusama et al., 2000). The M30 
monoclonal antibody has been used successfully for analyzing apoptosis especially in 
epithelial cells, of which placental villous trophoblasts are one type (Kadyrov et al., 
2001). 
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The TUNEL test has been established (Gavrieli et al., 1992) to detect cells that have 
reached a final stage of the apoptosis cascade and that will die soon. However, 
studies have shown that the number of apoptotic cells stained by M30 is higher than 
that stained by TUNEL, due to the longer period of cytokeratin cleavage within the 
apoptosis cascade, as compared to the short period of endonuclease activation 
(Huppertz et al., 1999; Robertson et al., 2000). Furthermore, within complex tissues 
such as the placental bed, evaluation of the TUNEL test is often limited by 
difficulties in distinguishing apoptotic trophoblast from other apoptotic cell types. 
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4.0 Summation and Aims 
During normal pregnancies extravillous trophoblast invade the myometrium via two 
pathways viz. interstitial and endovascular pathways. The spiral arteries are 
physiologically converted into large bore conduits. In preeclampsia, however, the 
endovascular pathway is compromised within the myometrium hence the arteries do 
not undergo conversion with a resultant inadquate supply of nutrients and oxygen to 
the developing foetus. Studies have shown that there is also an inadequate invasion 
of interstitial trophoblasts. This deficient invasion may be attributed to an increase in 
trophoblast apoptosis triggered by hypoxia due to the lack of spiral artery conversion. 
(Kilani et al., 2003). Alternatively, alterations in trophoblast expression of cell cycle 
markers may lead to abnormal placentation. The balance between trophoblast 
apoptosis and proliferation may represent a mechanism to control trophoblast 
invasion. 
Therefore, the aim of this study was to determine the immunoexpression profiles 
between trophoblast apoptosis (M30), and proliferation (Ki-67) in the placental bed 
of pre-eclamptic compared to normal pregnancies in an attempt to understand the 
imbalance that occurs in abnormal placentation. 
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CHAPTER TWO 
MA TE RIALS AND METHODS 
2.1 ETHICAL APPROVAL AND PATIENT CONSENT 
This retrospective study was conducted on placental bed biopsies that were obtained 
at the Obstetric Unit of King Edward VIII Hospital (KEH), Durban, South Africa 
(Reference Number R092/97). For this study, ethical approval was obtained from the 
Ethics Committee (Reference Number R 120/02), Nelson R. Mandela School of 
Medicine, University of Kwa-Zulu Natal. The placental bed biopsies were obtained 
as a non-routine procedure specifically as part of another study. 
2.2 MATERIALS 
The study group (n = 24) consisted of true placental bed wax embedded blocks 
obtained at caesarean section from normotensive (n = 12) and hypertensive (n = 12) 
pregnant women. The normotensive group (BP ::; 120/80 mmHg) was matched for 
maternal age with the hypertensive group (90 ::; DBP ::; I 00 mmHg- DBP � 110 
mmHg). Reasons for caesarean sections were previous caesarean section, fetal 
compromise and cephalo-pelvic disproportion. Patients' demographics were 
obtained. Parity ranged from O - 4. Retroviral status of these patients was unknown. 
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2.3 HISTOLOGY PREPARATION 
Three µm sections were cut from archived wax blocks on a Leica Jung microtome 
(RM2035). Sections were floated in a water bath and collected onto uncoated slides 
for histology. 
2.3.1 Haematoxylin & Eosin (H &E); Periodic acid Schiff reaction (PAS) and 
von Gieson elastic staining 
For each patient three sections (3 µm thick) were cut and stained for screening of the 
placental bed biopsy with the following stains: 
I. Haematoxylin and eosin staining (H & E): Mayer's Haematoxylin (Sigma
Chemicals, St Louis; Mayer, 1903) and 0.5% alcoholic eosin (BDH,
England);
2. Periodic acid-Schiff reaction (PAS; Pearse, 1953);
3. Von Gieson Elastic (EVG) staining.
The procedures used for the H & E and PAS and EVG are outlined in Table I, II and 
III respectively. Examination of the tissue was essential for the confirmation of a true 
















Procedure for H & E staining 
SOLUTION 
Dewax - xylene 
Rehydrate - absolute ethanol 
Rehydrate - 90% ethanol 
Rehydrate - 70% ethanol 
Rehydrate - water 
Mayer's Haematoxylin 
Blue - rinse in running tap water 
0.5% alcoholic eosin 
Rinse quickly by immersing slides in 95% 
ethanol 
Dehydrate - Absolute Alcohol 
Dehydrate - Xylene 
Mount in DPX 
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TIME 
2 x 5 min 








2 x I min 
I min 
Table II: Procedure for PAS staining 
STEP SOLUTION TIME 
1 Dewax - xylene 2 x 5 min 
2 Rehydrate - absolute ethanol 2 x 1 min 
3 Rehydrate - 90% ethanol I min 
4 Rehydrate - 70% ethanol I min 
5 Rehydrate - water I min 
6 I% Periodic Acid 10 min 
7 Rinse in running water 30 sec 
8 Schiff reagents (BDH, England) 15 min 
9 Running tap water 5 min 
10 Mayer·s Haematoxylin 2 min 
11 Blue in running tap water 2 min 
12 2% Orange-G (KGaA 64271, Merck, I dip 
Germany) in 5% Phosphotungstic acid 
13 Rinse in running tap water 2 min 
14 Dehydrate - Absolute alcohol 2 x I min 
15 Dehydrate - Xylene I min 
16 Mount in DPX 
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Table III: Procedure for von Gieson elastic staining 
STEP METHOD TIME 
I Dewax and bring to 95% alcohol 
2 Miller's solution (BDH, England) 60 min 
3 Rinse well 
4 Differentiate in 70% alcohol 
5 Wash well 
6 Van Gieson solution* 5 min 
7 Blot dry 
8 Dehydrate through alcohol 
9 Clear in xylene 2 min 
10 Mount in DPX 
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2.4 TISSUE PROCESSING FOR IMMUNOHISTOCHEMICAL STUDIES 
Tissue sections were cut at 2 µm thickness using sterile disposable blades on a rotary 
microtome (Leica Jung, RM2035). They were floated in a water bath and picked on 
poly-L-lysine (0.1 % ) coated glass slides (Sigma Chemicals, St Louis) for 
immunohistochemical staining procedures. The sections were then baked on a 
hotplate at 60°C for 10 min before dewaxing and bringing to water. 
2.4.1 Mouse anti-human cytokeratin antibody (Clone MNF 116) isolation and 
specificity 
Cytokeratin is the most sensitive marker for all types of trophoblastic elements 
(cytotrophoblasts, syncytiotrophoblast and intermediate trophoblast cells from day 12 
to full term placenta (Daya and Sabet, 1991 ). Monoclonal mouse anti-human 
cytokeratin, Clone MNF 116 (M82 I; Dako, USA) was initially utilised for the 
identification of the trophoblast cell population; however we progressed to 
cytokeratin 18 as it is affected in early apoptosis. 
Clone MNF I I 6 antibody reacts with an epitope that is present in a wide range of 
cytokeratins. Immunoblotting reveals a number of discrete 45 to 56.5 kDa keratin 
polypeptides. These include keratin numbers 6,8, 17 and 19 (Moll er al., 1982). This 
antibody shows a broad pattern of reactivity with human epithelial tissues from 
simple glandular to stratified squamous epithelium (Moll et al., 1982; Earl et al., 
1987). Epithelial cells are labelled whether they are ectodermal, mesodermal or 
endodermal in origin. Occasionally, the antibody shows cross-reactivity with uterine 
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myometrial muscle cells but this is a non-specific reaction occurring in cells that are 
clearly morphologically distinguishable from the trophoblast cell. 
2.4.1.1 Immunostaining schedule for anti-MNF 116 antibody 
Antigen retrieval using pepsin (0.01 % in HCI; 0.0 IM at 37°C for 10 min) was 
performed prior to commencement of an indirect immunoperoxidase staining 
schedule utilising diaminobenzidine as the chromogen. Tris buffered saline (0.0 I% 
tris, 0.9% sodium chloride, pH 7.6) was used throughout the procedure, except in the 
chromogen step where Tris-HCI buffer (0.05 M) was used. Bovine serum albumin 
was used as a blocking agent (Fraction V, Sigma A4503). The primary antibody 
dilution was 1: 1000. The secondary antibody, a biotinylated rabbit anti-mouse 
immunoglobulin ( I :400) was linked to streptavidin peroxidase conjugate (1: I 000) 
and detection of peroxidase activity was performed with 3, 3' -diaminobenzidine 
(Sigma D4418). Nuclear (Mayer's haematoxylin) and cytoplasmic (0.5% alcoholic 
eosin) staining was subsequently performed. This procedure is outlined in Table IV. 
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Table IV: Procedure for immunohistochemical localisation of anti-MNF 116 
STEP TREATMENT SOLUTION TIME 
1 Pretreatment pepsin (0.01%) in HCI (0.01M) 10 min 
(37°C) 
2 Blocking H2O2 (0.5%) + sodium azide (0.1 %) in 30 min 
endogenous methanol 
peroxidase 
3 Blocking BSA (2%) 15 min 
4 Primary Mouse anti-human cytokeratin (clone 120 min 
antibody MNF 116) (1/1000) 
5 Blocking BSA (2%) 15 min 
6 Secondary Biotinylated rabbit anti-mouse 30 min 
antibody immunoglobulin ( 1/400) + normal
human serum (1/25) 
7 Linking Streptavidi n peroxidase conjugate 30 min 
(I/ I 000) 
8 Detection of DAB JO min 
peroxidase 
activity 
9 Nuclear Mayer's haematoxylin 1 min 
staining 
10 Counter Alcoholic Eosin (0.5%) 10 sec 
staining 
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2.4.2 Immunohistochemical procedure for anti-Ki67 antibody 
2.4.2.l Rabbit Anti-Human Ki67 antibody 
Rabbit Anti-Human Ki67 antibody (Clone: Ki-67, lsotype: IgG 1) is a polyclonal 
antibody that reacts with an antigen present in the nucleus of proliferating human 
cells. Ki-67 expression occurs during the phase of the cell cycle designated as late 
GI, S, Mand G2. However during the GO phase, the antigen cannot be detected. 
The assessment of cell proliferation by the detection of Ki67 antigen in neoplastic 
cell populations has been shown to be of prognostic value. The polyclonal antibody 
(NCL-Ki67p) labels Ki67 antigen in the granular components of the nucleolus during 
late GI, S, G2 and M phases (Gerdes et al., 1984). There is a strong correlation 
between low or high Ki67 index and low or high grade histopathology of neoplasms 
(Gerdes et al., 1987). 
2.4.2.2 Immunostaining schedule for anti-Ki67 antibody 
The immunostaining schedule utilised is outlined in Table V; however, the following 
steps varied; 
a. Serum Blocking: normal goat serum blocking solution
b. Primary Antibody: Rabbit Anti-Human Ki67 (NCL-Ki67-P, Novocastra) diluted
I :3000 in PBS and incubated for I hour at room temperature.
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c. Secondary Antibody: biotinylated Goat Anti-Rabbit IgG (BA 1000, Vector
Laboratories) diluted l :500 in PBS and incubated for 30 minutes at room
temperature.
d. Detection: HRP-Streptavidin (SA-5004, Vector Laboratories) diluted I :500 in
PBS for 30 minutes at room temperature
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Table V: Procedure for immunohistochemical localisation of anti-Ki67 antibody 
STEP TREATMENT 
I Pre-treatment 
2 Blocking endogenous 
peroxidase activity 
3 Blocking 
4 Primary antibody 
5 Secondary antibody 
6 Linking 
7 Detection of 
peroxidase activity 
8 Nuclear staining 
* Tris buffered saline used throughout
SOLUTION 
Citrate buffer 
H202 (0.5%) + sodium 
azide (0.1 % ) in methanol 
BSA (2%) 
Rabbit Anti-Human Ki67 
(I :3000) 
biotinylated Goat Anti-
Rabbit lgG ( I :500) 













2.4.3 Cytokeratin 18 antibody isolation and specificity 
Monoclonal Mouse Anti-Human Cytokeratin 18, Clone DC10 (M7010 
DakoCytomation) labels epithelial expressing Cytokeratin 18 (Lane and Alexander, 
1990). CK 18 belongs to intermediate filaments which create a cytoskeleton in almost 
all cells. In contrast to other intermediate filaments Cytokeratins are made up of a 
highly multigene family of polypeptides with molecular masses ranging from 40-68 
kDA (Moll et al., 1982) 
2.4.3.1 Immunostaining schedule for anti-Cytokeratin 18 antibody 
The immunostaining schedule utilised is outlined in Table VI. 
a. Antigen retrieval : Citrate Buffer
b. Serum Blocking: normal horse serum blocking solution
c. Primary Antibody: Mouse Anti-Human Cytokeratin 18 (Clone DC I 0)
(DakoCytomation, M70 I 0). Optimal dilution I: I 00.
d. Secondary Antibody: Horse Anti-Mouse IgG (H+L), biotinylated (Vector
Laboratories, BA-2000). Optimal dilution I :500.
e. Detection: HRP-Streptavidin (SA-5004, Vector Laboratories) diluted I :500 in
PBS for 30 minutes at room temperature
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Table VI: Procedure for immunohistochemical localisation of Cytokeratin 18 
antibody 
STEP TREATMENT SOLUTION TIME 
1 Pre-treatment Citrate buffer 20 min 
2 Blocking H2O2 (3%) 10 min 
endogenous 
peroxidase activity 
3 Blocking Horse serum (5%) 15 min 
4 Primary antibody Mouse Anti-Human Cytokeratin 18 overnight 
(I: 100) 
5 Secondary Horse Anti-Mouse lgG (H+L), 60 min 
antibody biotinylated ( I :500) 
6 Linking HRP-Streptavidin ( I :500) 30min 
7 Detection of Diaminobenzidine 10 min 
peroxidase activity 
8 Nuclear staining Mayer's haematoxylin I min 
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2.4.4 Clone M30, Cytodeath mouse lgG2b antibody isolation and specificity 
Clone M30, Cytodeath mouse lgG2b antibody (214322/150, Roche) is obtained from 
Balb-c-mice. It recognises a specific caspase cleaved formalin-resistant epitope of 
the human cytokeratin 18 (CK 18) cytoskeletal proteins that is not detectable in 
native CK 18 of normal cells (Leers et al., 1999). Cytokeratins, in particular 
cytokeratin 18 are affected in early apoptosis (Caulin et al., 1997). Consequently, it is 
a unique tool for reliable determination of early apoptosis in tissue sections where it 
is specifically located cytoplasmically; however, non specific reactivity with nuclear 
antigens of highly proliferating cells can occur (Kronberger et al., 2000; Chen et al., 
200 I; Ban tel et al., 200 I). 
2.4.4.1 lmmunostaining schedule for anti-M30 antibody 
Endogenous peroxidase was blocked by incubation of sections in aqueous hydrogen 
peroxidase (3%). After a 10 minute wash in running tap water, antigen retrieval was 
performed. For this process, sections were incubated in Citric acid buffer (0.0 IM, pH 
6.0) in a pressure cooker placed within a 570W microwave. The sections were 
allowed to incubate for 1-2 minute once the valve escaped. The solution was 
thereafter cooled in running tap water for IO minutes and transferred to TBS-TT for 
20 minutes. 
This process was followed by a final rinse in TBS and the sections were then ringed 
with a PAP pen to create an incubation chamber. Blocking was performed with BSA 
(2%) and incubated for 30 minutes. 
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Primary antibody was diluted in 5% horse serum in TBS and incubated overnight at 4 
0
c (dilution I :50; Roche). Sections were washed 3X 5 minutes in TBS-TT. The 
secondary antibody, a biotinylated horse anti-mouse immunoglobulin ( I :200 in 5% 
horse serum in TBS; BA 2000-Vector) was linked to a pre-formed Avidin and 
biotinylated horseradish peroxidase macromolecular Complex for 45 mfoutes at room 
temperature (Vectastain Elite ABC Kit; PK 6100 - Vector). Detection of peroxidase 
activity was performed with diaminobenzidine. Nuclear (Mayer's haematoxylin) 
staining was subsequently performed followed by dehydration and mounting of 
sections with DPX. This procedure is outlined in Table VII. 
2.4.5 Control 
For method controls, the primary antibody was replaced with a non-immune serum of 
the same IgG class. 
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7 Detection of 
peroxidase activity 
8 Nuclear staining 
SOLUTION 
Citrate buffer 
H2O2 (3%) in water 
BSA (2%) 
Clone M30, Cytodeath 
mouse IgG2b ( I :50) 
biotinylated horse anti-
mouse immunoglobulin 
( 1 :200) 















2.5 IMAGE ANALYSIS 
Image analysis is the process that extracts quantitative data from images. 
2.5.1 Measurement Strategy 
Initially, tissue sections were examined and areas of interest were photographed with 
a Nikon binocular Optiphot photomicroscope using 160 ASA colour film (Eastman­
Kodak, USA). Subsequently, all fields of interest were digitised with a 3CCD Sony 
colour video camera interfaced with the Nikon Optiphot microscope that was linked 
to the Kontron Systems 300 image analysis system. For every specimen, 3 areas of 
the myometrium that did not contain a vein or any artery were also selected and 
stored. All cross sections of the spiral artery appearing on a particular slide were also 
included. 
Areas of interest were viewed at an initial magnification of X40 prior to storage as a 
digital image (Fig 12a). A scale bar was then inserted on a graphics overlay and 
merged onto the image plane prior to storage as a 24 bit tagged image format. Due to 
the unavailability of a true colour densitometric setting on the KS 300 system used, 
all images were converted into grey images (Fig 12b). A true colour densitometric 
system would enable one to read the intensity of the DAB reaction as a range of 
brown on a colour scale. However, in the system used the intensity of the grey image 
is represented as numbers ranging from black (0) to white (255). 
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Automatic contrast adjustment of the grey image was performed on all digitised 
images (Fig 12c ). All results reflect this uniform contrast enhancement. 
The immunoreactive areas were easily detected, appearing dark grey to black on the 
image. These regions were segmented from the image on the basis of their grey 
scale. This process created a binary image (containing only 2 grey values - 0 and 
255; Fig 12d) which defined the immunoreactive areas (white) to be analysed. 
Sometimes, filling of holes in certain selected regions or deletion of regions in a 
specified size range was necessary (deletion is illustrated in Fig I 2e). Regions 
consisting of nuclei were routinely scrapped as their grey value often overlapped with 
that of the chromogen (DAB). 
For quantitation purpose, the image was geometrically calibrated according to the 
initial magnification. lmmunoreactive regions were expressed as a percentage of the 
frame area. A record of measurements was extracted from the binary image according 
to predefined speci fie features. To validate the regions measured, a draw mask 
(segmented areas) of the binary image was superimposed onto the original image 
plane (Fig I 2t). Measurement values consisted of the defined measurement 
parameters as a data list and were stored in a database file. For vessel assessment, the 
area of the spiral artery wall was calculated by subtracting the area of the lumen from 
the area of the outer adventitial boundary (Fig 13 ). Trophoblast cells were expressed 
as a percentage of the wall area. The predefined measurement parameters and their 
definitions are listed below: 
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1. FLO COUNT :
2. FLDAREA:
3. FLDAREAP (%)
Number of measured regions 
Area of all regions 
Percentage area of all regions in measurement 
frames 
4. FRAME AREA (µm2) Area of measurement frame 
5. FRAME AREA I (pixels
2
) Unscaled area of the measurement frame
6. FLDMEAND Mean grey value of all regions 
7. FLDSTDD Grey value standard deviation in all regions 
8. FLDMIND Minimum grey value in all regions 
9. FLDMAXD Maximum grey value in all regions 
Table VIII shows steps formulated in the macro drawn-up for image analysis. The 
macro is pictorially illustrated in Fig 12a-f. Database files were created for the 
myometrium and myometrial spiral arteries immunostained with MNF 116, CK l8, 
M30 and Ki67 antibodies in both the normal and hypertensive groups. Descriptive 
statistics were also used and presented as FLDAREAP(%) ± SD (FLDMIND­
FLDMAXD). T-tests were done in Epicalc software to make pairwise comparisons 
(Epicalc 2000, version 1.02). Values were considered statistically significant at a p 
value<0.05. 
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Table VIII: Steps formulated in the macro utilised for image analysis of 
antibody distribution 
Step Macro command 
I Tvselect"WVFG METEOR" 
2 Imgdelete 1 
3 Imgdelete 2 
4 Imgdelete 3 
5 Imgdelete 4 
6 lmgdelete 5 
7 Gclear 0 
8 Tvlive 
9 Tvinput I 
10 Imgload"d:\enbavani\masters\5600CK I 8x 10.tif, I 
I 1 imgRGB2grey 1,2 
12 Normalise2,3,5 
13 Dislev 3,4,52, 197, I 





19 MSmeasmask 5, I , "methods", I ,2, I 0 
20 MSdrawmask 5, I 
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Fig 12a-f: Gallery of images of selected field for spiral artery analysis. 
a-colour image of spiral artery immunoreactive CK18
b-black and white image of (a)
c-contrast enhanced black and white image of (b)
d-CKI 8 segmented image
e-scrapping of CKI 8 non-specific regions
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Fig 13: Computed light micrograph of spiral artery 
depicting segmented lumen and outer vessel wall. The 
area of the spiral artery wall was calculated by 
subtracting the area of the lumen from the area of the 
outer adventitial boundary. 
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3.1 Patient Population 
CHAPTER3 
RESULTS 
This retrospective study examined true placental bed biopsies obtained at caesarean 
section from a study population consisting of 12 women with normal pregnancies and 12 
women with hypertensive pregnancies. 
3.1.1 Demographic and clinical data of normotensive pregnant group 
Twelve women with parity ranging 0 - 4 (mean: 2), mean age of 26 (range: 18 - 35) yrs, 
gestational age 2'. 30 weeks (mean: 39; range: 30 - 41 weeks) and mean gravida of 2 
(range: I - 5) and a mean DBP of 80 ± 6 (95%CI: 74 - 79) mmHg had successful 
placental bed biopsies. The mean infant birth weight was 2.9 ± 0.50kg. 
3.1.2 Demographic and clinical data of Pre-eclamptic group 
Twelve patients with preeclampsia had a mean systolic blood pressure of 183 (95%CI: 
168 - 198) mmHg and mean DBP of I 15 (95%CI: I 10 - 120) mmHg. The mean age of 
these patients were 25 (range: I 7 - 33) yrs, parity ranged from 0 - 4 (mean: I), mean 
gravida of 2 (range: I - 5) and gestational age 2'. 29 (mean: 35; range: 29 - 4 I) weeks. 
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The mean birthweight of the newborns was 2.22 ± 0.62 kg. All patients demonstrated an 
elevation of urinary protein (> 0.3 g/d). 
Gestational ages at delivery in the pre-eclamptic group were significantly lower 
compared to the normotensive pregnant group (p<0.001). In addition, all babies were 
born alive except for one stillbirth in the pre-eclamptic group. The clinical 
classification, demographic characteristics and peri-natal outcome of the two groups of 
patients are listed in Table IX. 
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Table IX: Clinical Classification of Two Groups of Patients in the study 
NORMOTENSJVE 
PREGNANT 
(n= I 2) 
Age (yr) 26 (18-35) 
Gestation (weeks) 39 (30-4 I) 
Parity 2 (0-4) 
Gravidity 2 (1-5) 
Blood Pressure (mmHg) 
Systolic 120 ± 9* 
95%CJ ( I 15 -123) 
Diastolic 80 ± 6* * 
95%CI (74 - 79) 
Mean Birth weight (kg) 2.9 ± o.50*** 
• normotensive vs hypertensive group p< 0.000 I;
• *
normotensive vs hypertensive group p< 0.000 I;
* • • normotensive vs hypertensive group p< 0.00 I




(n= I 2) 
25 ( 17-33) 
35 (29-41) 
I (0-4) 
2 ( 1-5) 
183 ± 22 
( I 68-198) 
115 ±7 
(110 -120) 
2.22 ± 0.62 
3.2 Histology of true placental bed biopsies 
Histopathological examinations of tissue samples were carried out on Haematoxylin and 
Eosin (H&E), Periodic Acid-Schiff Reaction (PAS) and Elastic Von Gieson (EVG) 
stained sections. For recognition of trophoblast cell populations, an 
immunocytochemical staining protocol using either anti-MNF 116 or anti-Cytokeratin 
18 as the primary antibody was examined. 
Inclusion criteria used for histological identification of true placental bed biopsies were 
the presence of: 
i) myometrial interstitial mononuclear cytotrophoblast,
ii) myometrial interstitial multinucleate giant cells,
iii) spiral arteries within the myometrial segment were the most striking feature used
in confirming true placental bed biopsies in normal and hypertensive
pregnancies.
3.2.1 Normotensive Group 
All twelve placental bed biopsies contained the inclusion criteria for their classification 
as true placental bed biopsies. Distributed within the myometrium were spiral arteries 
displaying total physiological change as shown in H&E (Fig 14), PAS (Fig 15) and EVG 
(Fig 16) stained sections. The spiral arteries resembled sinusoids with large lumens. 
The walls of the spiral artery were fibrinoid in nature and lacking the typical muscular 
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elastic tunica media (Fig 14-16). Serial staining of sections were routinely performed 
(Figures 14-16). 
Von Gieson's Elastic stained sections revealed the elastic content of the arterial wall to 
be reduced in the normotensive group compared to the hypertensive groups (Fig 16). 
Invading trophoblast cells as identified by MNFI 16 were found embedded within the 
fibrinoid wall of the spiral artery (Fig 17 and 18). These cells had long spider-like 
cytoplasmic projections (Fig 18). Sub-intimal thickening of the vessel was noted (Fig 
18). The lumen was lined by endothelial cells. Endovascular trophoblasts were only 
observed within the lumen of one spiral artery. 
Mononuclear invading trophoblast cells were observed in the myometrial interstitium 
occurring singly (Fig 19) or in streams (Fig 19). Multinucleated interstitial trophoblast 
cells often referred to as giant cells were observed in the vicinity of vessels and also 
occurred free within the myometrial interstitium (Fig 20 and 21 ). Large arcuate and 
small basal arteries were observed traversing the myometrium (Fig 22). Myometrial 
glands were also noted in some of the biopsies (Fig 23). The glandular epithelium 





Fig 14: Micrograph showing physiologically converted myometrial spiral 
artery stained with H & E. Lumen (L), Fibrinoid wall (F). 
Fig 15: Micrograph showing physiologically converted myometrial spiral 
artery stained with PAS. Note that the orientation of section is reversed. 
Lumen (L), Fibrinoid wall (F). 
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Fig 16: Micrograph showing physiologically converted myometrial spiral 
artery stained with EVG. Lumen (L), Fibrinoid wall (F) 
, 
100.00 
Fig 17: Micrograph immunostained with anti-MNF I 16 showing total 
physiological conversion of spiral artery (arrow) whilst adjacent c/s of artery 
shows partial physiological conversion (clear arrow). Note also trophoblast 
cells (T). 
66 
Fig 18: High power micrograph illustrating cytoplasmic extensions 
(arrow) of the trophoblast cells embedded in the fibrinoid wall (F) of the 
spiral artery. Note lumen (L) and intimal cushion (I). 
Fig 19: Micrograph immunostained with anti-MNF 116 depicting interstitial 
invasion of myometrium - singly (arrow) or in streams (clear arrow). Vein 
(V). 
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Fig 20: Micrograph immunostained with anti-MNF 116 showing myometrial 
interstitial invasion by trophoblast cells. Note also giant cells (GC). 
micron -- -
100.00 
Fig 21: High power micrograph of multinucleated giant cell (GC) within 




Fig 22: Micrograph immunostained with anti-MNF I 16 illustrating large 
arcuate artery (arrow) occurring in preeclamptic group. 
Fig 23: Micrograph immunostained with anti-MNF 116 depicting cross 
reactivity of primary antibody. The myometrial glandular epithelium (arrow) 
as well as the trophoblast cells (clear arrow) appears immunopositive. 
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3.2.2 Pre-eclamptic Group 
All biopsies from this group that were adequate for assessment confirmed previous 
reports of lack of extravillous trophoblastic invasion of the spiral artery within the 
myometrial segment of the placental bed, that is there was an absence of physiological 
conversion of the spiral arteries (Fig 24) . Extensive reduction of lumen diameter was 
noted in these non-converted spiral arteries. Hyperplastic media of these non-converted 
arteries were clearly noted in H&E and PAS stained sections (Fig 25-26). Marked 
hyperplasia was associated with narrowing of the lumen (Fig 24-25). Perivascular 
mononuclear lymphocyte cell infiltrate were observed (Fig 25). Reduplication of the 
elastic lamina was noted in EVG stained sections (Fig 27). Endothelial vacuolation (Fig 
28), intimal thickening and disorganization and hyperplasia of the media (Fig 29) were 
observed. 
Invasive trophoblast cells as immunostained by MNF 116 were observed within the 
interstium of the myometrium occurring both mono and multi-nucleated (Fig 30 & 31 ). 
Other pathological features noted were acute atherosis as well as perivascular 
trophoblast cells (Fig 28-29). No intraluminal trophoblast cells were noted within spiral 
arteries. Qualitatively, it was noted that there was a decrease in interstial trophoblast 






Fig 24: H&E stained section showing cluster of three myometrial spiral 
arteries occurring within the preeclamptic group . 
• 
Fig 25: High power micrograph of figure above illustrating small lumen of 
artery, endothelial cell vacuolation and perivascular aggregation of 
polymorphonuclear lymphocytes (arrow). 
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Fig 26: PAS stained section from preeclamptic group showing medial 
hyperplasia as well as medial disorganization of non converted spiral artery. 
Fig 27: EVG stained section of spiral artery in pre-eclamptic group 
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Fig 28: Micrograph immunostained with anti-MNF 116 showing 
perivascular localization of trophoblast cell (arrow). 
Fig 29: Micrograph immunostained with anti-MNF 116 from preeclamptic 
placental bed showing spiral artery with extensive hyperplasia of media and 
reduced lumen. Note also close peripheral proximity of trophoblast cells 
(arrows) to spiral artery. 
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Fig 30: Micrograph immunostained with anti-MNF 116 showing basal 
arteries (arrow) and interstial trophoblast cells. 
Fig 31: Micrograph immunostained with anti-MNF 116 illustrating 
myometrial interstitial trophoblast cells. Section shows large numbers of 
giant cells (arrows). Vein (V) 
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3.3 Anti-CK18 and anti-Ki67 lmmunoreactivity 
Serial sections immunostained for anti-CK18 and anti-Ki67 respectively were viewed 
concurrently for all samples. The anti-cytokeratin 18 vs anti-Ki67 immunoreactivity 
within placental bed of normotensive and hypertensive pregnant women is outlined in 
Table X. 
In the normotensive pregnant group, spiral arteries that had undergone a total or partial 
physiological conversion displayed an intense anti-CK 18 immunopositivity of 
intramural trophoblast cells embedded in the fibrinoid artery wall (Fig 32; 34; 36) with a 
concurrent total absence of immunoreactivity to Ki67 antibody (Fig 33; 35; 37). No 
immunoreactivity of the fibrinoid wall was observed for both antibodies. 
Endothelial cells lining spiral arteries that had undergone a physiological change were 
non-reactive to anti-Ki67 (Fig 33; 35; 37) However in one specimen that displayed 
endovascular trophoblast cells within the lumen of a spiral artery (Fig 36), the 
endothelial cells displayed intense reactivity to anti-cytokeratin 18 (Fig 36). Both the 
endovascular trophoblast cells as well as the endothelial cells appeared non-reactive to 
anti-Ki67 (Fig 37). Perivascular cytotrophoblast cells were strongly immunoreactive to 
anti-CK 18 but non-reactive to anti-Ki67 (Fig 38-39). 
In the pre-eclamptic group, spiral arteries with extensive hyperplasia displayed absence 
of reactivity to anti-cytokeratin 18 (Fig 38 & 39). However, a nil to mild anti-Ki67 
immunoreactivity was occasionally noted (Fig 40 & 41 ). Distinct immunoprecipitation 
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of anti-Ki67 were observed in smooth muscle cells of the microvasculature (Fig 42-45). 
In addition, the endothelial cells lining these small calibre lumens displayed an absence 
of immunoreactivity to anti-Ki67 (Fig 43 & 45). 
Both mononuclear and multinucleated trophoblast giant cells, displayed intense 
immunostaining reaction to anti-CK I 8 with an absence of immuno-reactivity to anti-
Ki67 (Fig 42-45). 
For both antibodies, substitution of the primary antibody with non-immune sera of the 
same IgG species as the primary antibody produced an absence of reaction product (Fig 
46 & 47). 
In summary, immunocytochemical detection of anti-Ki-67 indicated no significant 
differences in the extravillous trophoblast proliferation within the myometrium of the 
placental beds of normal and pre-eclamptic beds. However, smooth muscle cells of the 
small caliber microvasculature were immunostained with Ki67, indicating proliferation 
of these cells. The multinucleated trophoblast cells in both groups demonstrated an 
absence of proliferation. 
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Table X: anti-Cytokeratin 18 vs anti-Ki67 Immunoreactivity within placental bed of 
normotensive and hypertensive pregnant women 
Normotensive Hypertensive 
Ck18 Ki67 Ck18 Ki67 
Trophoblast cells in wall of converted + - + -
spiral artery 
Fibrinoid of converted spiral artery - - - -
Endothelial cell of spiral artery +* - - -
Smooth muscle cell of non converted spiral - - - + 
artery 
Peri vascular trophoblast cell + - + -
Interstitial mononuclear trophoblast cells + - + -
Interstitial multinucleated trophoblast cells + - + -
Microvascualture- smooth muscle cells - + - + 
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Fig 32: Physiologically converted spiral artery from placental bed of 
normotensive patient immunostained with anti-CK18. Note trophoblast cells 
(arrow) in fibrinoid wall as well as myometrial interstitial trophoblast cell 
(IT). Lumen (L), vein (V). 
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Fig 33: Serial section of Fig 32 immunostained with anti-Ki67 showing total 
absence of immunoreactivity in the trophoblast cell sub-populations. 
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Fig 34: Spiral artery with partial physiological conversion immune-stained 
with anti-CKl8. Note immunoreactivity of trophoblast cells (arrow) in wall 
































Fig 35: Serial section of Figure 34 illustrating non-reactivity of trophoblast 









Fig 36: Cytokeratin positive section illustrating portion of physiologically 
converted spiral artery with Lumen (L) infiltrated by endovascular 
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Fig 37: Serial section of Figure 36 illustrating non-reactivity of endovascular 
trophoblast (arrow) within lumen of spiral artery immunostained for Ki67. 
Note fibrinoid wall (F) and giant cell (GC). Lumen (L); vein (V) 
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Fig 38: Cytokeratin positive section of non-physiologically converted artery 
from hypertensive patient illustrating reactivity of perivascular trophoblast 
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Fig 39: Deeper serial section of Figure 38 illustrating non-reactivity of anti­
Ki67 within nonconverted spiral artery. 
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Fig 42: Section immunostained with anti-CK 18. Note giant cells (GC) as 












Fig 43: Serial section of Figure 42 immunostained with anti-Ki67. Note 
absence of immunoreactivity within non invasive trophoblast giant cells 






























Fig 44: Micrograph of myometrium immunostained with anti-CK 18. Note 















Fig 45: Serial section of Figure 44 showing non-reactive giant cells (clear 
arrow) with moderate Ki67 immunoreactivity (arrow) of smooth muscle cells 
of basal artery. 
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Fig 46 Method control for anti-CK 18 
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3.4 Anti-CK18 and anti-M30 lmmunoreactivity 
The distribution of anti-CK 18 vs anti-M30 i mmunoprecipitation pattern within the 
placental bed of normotensive and hypertensive pregnant women is outlined in Table XI. 
On serial sections immunostained with anti-CK 18 and anti-M30 (Figures 48-49 and 50-
51 respectively), the profiles of spiral arteries were visualised and assessed. In both 
study groups, trophoblast cells were immunopositive for anti-CK I 8, but qualitatively 
reduced for anti-M30. Intramural trophoblast cells embedded within the fibrinoid wall 
of spiral arteries that are immunoreactive to M30 antibody is shown in Fig 49 and 51 
compared to a non-reaction in the pre-eclamptic group (Fig 55). 
In both study groups mononuclear and multinucleated interstitial trophoblast cell 
profiles were immunoreactive for anti-CK 18 but varied for MJO (Fig 52-53 and 56-57 
respectively). 
Substitution of the primary antibody with non-immune sera of the same IgG class 
produced no reactivity (Fig 46 and 58). 
3.4.l Image analysis of anti-CK18 relative to M30 immunoexpression 
Morphometric image analysis of anti-CK 18 and M30 immunoexpression within 
trophoblast cells embedded in the fibrinoid wall of the spiral artery within normotensive 
groups was performed. The area of the wall of the spiral artery (C) was calculated by 
subtracting the lumen (B) area from the entire artery diameter using the outer adventitial 
vessel boundary (A). The area of the wall of the spiral artery of the normotensive group 
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was 3 I 1729 ± 51 I 80 µm2 compared to a significant decrease in area of 35795 ± 8045 
µm
2 
in the preeclamptic group (p < 0.000 I). The lumen of the spiral artery was
significantly decreased in the preeclamptic group compared to the normotensive (657 ±
106 µm
2 
vs 102379 ± 60045 µm2 respectively, p=0.000007; Table XII). The reduction
in the area of spiral artery in the normotensive group compared to the pre-eclamptic 
group is illustrated in Fig 59. 
The mean field area of trophoblast cells (anti-CK 18) embedded within the fibrinoid wall 
of the spiral waJI artery in the normotensive group was 13 ± 5 % compared to 0% in the 
non-converted spiral arteries of the preeclamptic group (p < 0.000 I). The intensity 
profile varied from 0 - 230 DensUnit. M30 distribution on corresponding serial sections 
were 2.5 ± 0.7% with an intensity profile of 0 - 154 DensUnit for the normotensive 
group with an absence (0%) of reactivity in the non-converted spiral artery (p < 0.0001). 
The mean field area of the interstitial trophoblast (anti-Ck 18) invasion in the 
preeclamptic group was 2.87 ± 0.5% compared to 10.79 ± 4.2% in the normotensive 
group (p < 0.000 I). However the serial sections immunostained with M30 showed 
elevation of apoptotic invasive interstial trophoblast in preeclamptic compared to the 
normotensive group ( 1.9 ± 0.5% vs 0.8 ± 0.3%; p=0.00 I). Figure 60 schematically 
illustrates the reduction of trophoblast cells in the normotensive group compared to the 
preeclamptic group. It also illustrates the elevation of apoptosis in the preeclamptic 
group. 
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Table XI: Cytokeratin 18 vs M30 Immunoreactivity within placental bed of 
normotensive and hypertensive pregnant women 
Normotensive Hypertensive 
n=l2 n=l2 
Ckl8 M30 Ck18 M30 
Trophoblast cells in wall of spiral + +/- - -
artery 
Fibrinoid of spiral artery - - - -
Endothelial cell of spiral artery - - - -
Perivascular trophoblast cell + +/- + +/-
Interstitial mononuclear trophoblast + +/- + +/-
cells 











Fig 48: Micrograph illustrating anti-CKl 8 immunoreactivity within 
trophoblast cells (arrow) embedded in fibrinoid wall of spiral artery with 














Fig 49: Serial section of Figure 48 immunostained with anti-M30. Few 










Fig 50: Micrograph of cross sections through loops of spiral arteries. Note 
immunoreactivity of trophoblast cells to anti anti-CK 18 (arrow). Lumen (L). 
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Fig 51: Mild to moderate immunoreaction product within trophoblast cells 


































Fig 52: Myometrial interstitial trophoblast cells (arrow) immunoreactive to 
anti-anti-CK18 from the normotensive group. Note immunoreactivity of 
glandular epithelium (G). Vein (V). 
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Fig 53: Serial section of Fig 52 depicting myometrium immunostained with 
anti-M30. Note absence of reaction product within glandular epithelial 
cells (G). Few interstitial trohoblast cells are reactive (arrow). 
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Fig 54: Micrograph of non physiologically converted spiral artery. Note 
absence of trophoblast cells and reduced lumen (L) 
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Fig 55: Serial section of 
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non physiologically converted spiral artery 








Fig 56: Micrograph illustrating interstitial trophoblast (arrow) population 
imrnunoreactivity anti-CK18 from the preeclamptic group. Note 













Fig 57: Serial section of Figure 56 illustrating interstitial trophoblast (arrow) 




Fig 58: Method control for M30 
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Table XII: Mean area of spiral artery parameters in placental bed biopsies 
Mean Area µm1
Artery inclusive of Lumen (B) Artery Wall (C) 
lumen (A) A-B==C 
N ormotensi ve 414109 ± 57072 I 02379 ± 60045 311729 ± 51180 
n=l2 
Preeclamptic 36452 ± 9000 657± 106 35795 ± 8045 
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Fig 59: Histogram depicting area occupied by spiral artery, lumen and arterial wall 
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Table XIII: Image analysis of anti-CK18 vs M30 immunoexpression 




















10.79 ± 4.2 
2.5 ± 0.7 
0.8 ±0.3 
-- - - ---
Preeclamptic 
0 
p < 0.0001 
2.87 ± 0.5 
p=0.000002 
0 
p < 0.0001 
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Fig 60: Histogram illustrating anti-CK and M30 immunoreactivity within interstititial 




The placenta is a temporary organ that undergoes growth and development followed 
by senescence and death in nine months (Austgulen et al., 2002). Placental growth 
depends on cytotrophoblast proliferation. A portion of cytotrophoblasts, which retain 
an undifferentiated phenotype throughout pregnancy, provide a reservoir of stem 
cells. The remaining cytotrophoblasts give rise to the two major trophoblasts 
subpopulations, syncytial trophoblasts and invasive cytotrophoblasts. 
Controlled invasion by these cytotrophoblast stem cells of uterine decidua, 
myometrium and spiral arteries are essential for normal fetoplacental development. 
The interstitial trophoblast penetrates decidual tissues reaching the inner third of the 
myometrium. A subset of the trophoblast population, the endovascular trophoblast 
transforms uterine spiral arteries into large-bore conduits to enable the adequate 
supply of nutrients and oxygen to the placenta and thus the fetus. However, in the 
pregnancy disease preeclampsia, cytotrophoblast differentiation is abnormal and 
invasion is shallow. In recent years a number of studies have defined the molecular 
mechanisms, intrinsic to extravillous trophoblast, that appear to limit invasiveness of 
these cells into the uterine wall (Graham and Mccrae, 1996; Zhou et al., 1997). 
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Apoptosis is believed to play a role in the development, remodeling and aging of the 
placenta (Smith et al., 1997). The balance between trophoblast differentiation, 
proliferation and apoptosis may represent a mechanism to control normal trophoblast 
invasion (Genbacev et al., 1997). Alternatively, alterations in mjtotic regulators of 
the trophoblast cell cycle may provide the basis for understanding factors that lead to 
abnormal placentation. Extravillous cytotrophoblast progression through and exit 
from the cell cycle as a function of differentiation is not well studied. Control of 
trophoblast invasion is still a mystery and therefore this study examines the 
imbalance between proliferation and apoptosis as possible mechanisms for the 
aberrant invasion that occurs in preeclampsia. The pathogenesis of preeclampsia may 
be due to an increase in apoptosis of trophoblast eel Is (Lyall and Myatt, 2002). 
The use of immunohistochemical methods has become a widely accepted means of 
determining the state of cellular proliferation in histological material, because it 
allows architectural and cytological features to be preserved and avoids the in vivo
administration of thymidine analogues (Hall and Wood., 1990). In recent years, 
evaluation of cell proliferation associated antigens by immunohistochemistry has 
evoked the interest of histopathologists. One of the most widely used reagents in this 
field is the Ki67 antibody which reacts with a nuclear non-histone protein of 395 and 
345 kilodaltons present in active parts of the cell cycle, i.e. GI , S, G2, and mitosis but 
is absent in GO (Sholzen and Gerdes, 2000). The diagnostic and prognostic value of 
Ki67 immunostaining in tumours has been well documented (Gerdes., 1990; Hall and 
Wood, 1990). Other proliferation cell markers, such as proliferation cell nuclear 
antigen, are expressed in non-cycling cells for example in association with DNA 
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repair, so that they tend to persist after the end of mitosis leading to an over­
estimation of the degree of proliferative activity in a tissue, due to retention of 
staining in post-mitotic cells (Elston and Bagshawe, 1972). 
The Ki67 immunoexpression seems to have a logical correlation with the 
proliferative activity in normal placentas being very active in first trimester placentas 
but diminished in term placenta (Suresh et al., 1993). Interestingly, the prognosis of 
molar pregnancies cannot be determined using the Ki67 proliferative index (Cheung 
et al., 1994). In this study, we demonstrate an absence of immunoexpression of Ki67 
within the extravillous trophoblast population of the myometrium of both normal and 
pre-eclamptic placental bed biopsies by immunocytochemical techniques. As the 
presence of the Ki-67 antigen is strictly associated with the cell cycle and confined to 
the nucleus, this finding suggests an exit from the cell cycle. Ki-67 is a constituent of 
compact chromatin (Kreitz et al., 2000) and hence is vital for the maintenance and/or 
regulation of the cell division cycle. 
Bulmer and co-workers ( 1988) have used single and double immunohistochemical 
labelling to examine expression of apoptosis and cell cycle markers by villous and 
extravillous trophoblast in matched placentas and placental bed biopsies from normal 
pregnancies, 8-20 weeks gestational age and at term. Cytotrophoblast columns were 
positive for the proliferation marker anti-Ki67 even in the second trimester but 
interstitial and endovascular trophoblasts were always anti-Ki67 negative. In 
accordance with the latter study, this study, demonstrates non-reactivity of anti-Ki67 
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in both intramural/endovascular and interstitial trophoblast cell populations within 
normal and preeclamptic placental bed biopsies at term gestation. 
In another study, immunostaining of first trimester placental bed biopsy specimens 
with an antibody against the Ki67 antigen, revealed that its expression abruptly stops 
at sites where cytotrophoblasts differentiate and attach to the uterine wall (Genbacev 
et al., l 997). Our observations within the myometrial extravillous trophoblast 
population at term gestation conforms to this data further corroborating the fact that 
differentiation of invasive cytotrophoblast cells is coordinated with exit from the cell 
cycle. The expression patterns of G 1 and G2 cyclins and of their cyclin-dependant 
kinases further supports this hypothesis (Genbacev et al., 2000). 
Multinucleated giant cells are regarded as degenerative non-inva ive extravillous 
trophoblast cells. In this study, the multinucleated trophoblast cell population were 
usually scattered within the interstitium of the myometrium and were non-reactive to 
Ki67 antibody in both normotensive and pre-eclamptic groups. These findings 
suggest that these multinucleated trophoblast cells are non-proliferative and non­
functional at term gestation. Interestingly, endoreduplication, the differentiation 
pathway that gives rise to trophoblast giant cells in the mouse, is also characterised 
by the expression of an unusual set of cell cycle regulators (MacAuley et al., 1998). 
Preeclampsia is characterised by hyperplasia of the smooth muscle cells of spiral 
arteries. In this study, there was an increase of proliferation of the smooth muscle 
cells of the hyperplastic spiral arteries in the preeclamptic group as they displayed a 
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mild degree of immunopositive staining to Ki67. This observation alludes to a slight 
increase in proliferation of the smooth muscle cells associated with the hypoxic 
microenvironment that occurs in preeclampsia. Furthermore, the additional 
observation of distinct immunoreactivity within smooth muscle cells of the 
myometrial microvasculature denotes proliferation. Hypoxia has been suggested as 
one of the micro-environmental factors that can modulate the phenotype of vascular 
smooth muscle cells in vivo and in vitro. It has also being shown to induce 
proliferation of vascular smooth muscle cells (Butler et al., 1988; Dempsey et al., 
1991 ). In this study, the lumen of the spiral artery was significantly decreased in the 
preeclamptic group compared to the normotensive (657 ± I 06 µm
2 
vs I 02379 ±
60045 µm
2 
respectively) indicating reduced blood supply to the developing fetus.
This data conforms to and adds to data of earlier investigators (Brosens et al., 1967) 
who have demonstrated a positive correlation between trophoblast invasion and 
arterial dilation and a negative correlation between preeclampsia and arterial 
trophoblast invasion (Brosens et al., 1972; Meekins et al., 1994). Both these studies 
confirm that the microenviroment of the placental bed is relatively hypoxic. Ki67 has 
also being implicated in GI arrest in a variety of tumor cell lines (Graeber et al., 
1994). Both these features has important implications as they suggest that ischemia 
can traumatize muscle tissues by killing cells and modulating differentiated cells to 
proliferate and thereby compromising the structural and functional integrity of the 
tissue. An alternate explanation may be attributed to the fact that hypoxia in 
proliferating cells can induce aberrant DNA replication patterns (Rice, 1984; Young 
et al., 1989). 
The present study also utilises immunoexpression of CK 18 and its neo-epitope M30 
for assessing trophoblast apoptosis in placental bed of normal and preclamptic 
pregnancies, at term. This immunohistologic method of detecting apoptosis has been 
developed using alterations of CK 18 as it is widely distributed in epithelial cells. It 
has been suggested that the M30 antibody that recognises the CK 18 epitope does not 
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react with necrotic and vital epithelial cells (Kadyrov et al., 200 I). As trophoblasts 
are epithelial in origin CKl8 is a component of their cytoskeleton (Morsi et al., 
2000). 
Apoptosis has being found in placentas throughout gestation using many techniques, 
including light microscopy, electron microscopy, and terminal deoxynucleotidyl 
transferase-mediated deoxyuridine triphosphate marker nick-end labeling (TUNEL) 
staining (Smith et al., 1997). The TUNEL method, however, detects DNA 
fragmentation in all kinds of cells, whereas M30 staining can be expected only in 
CKl 8-containing cells. Furthermore, the TUNEL method and M30 staining recognise 
different aspects and steps of the apoptotic pathway. Since the neoepitope of CK 18 is 
unmasked early in the apoptotic cascade, and DNA degradation occurs late in the 
process, one would expect that M30 antibody may be more sensitive for the detection 
of apoptosis. Smith et al ( 1997) reported that placental apoptosis occurs more 
frequently in pregnancies complicated by FGR. The latter authors found an apoptotic 
rate of 0.05% in normal term placenta, whereas Bulmer et al ( I 988) observed an 
apoptotic rate of approximately 0.03% in villous tissues. Recently, a report of M30 
staining and extravillous trophoblast apoptosis has been published (Kadyrov et al., 
2001 ). 
In this study, there was positive anti-CK 18 immunoreactvity in all extravillous 
trophoblast cell populations within the placental bed of normotensive and 
preeclamptic placental bed biopsies. This reactivity was evident in the intramural 
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trophoblast cells embedded in the fibrinoid wall of the physiologically converted 
spiral artery and within the invasive interstitial trophoblast cells of the myometrium. 
Morphometric image analysis in the present study indicates a reduction of intramural 
trophoblast invasion in the spiral artery to a non-invasion in the pre-eclamptic group 
(13% vs 0% for CKl 8 immunoreactivity for both groups respectively). In another 
study, Naicker et al (2003) demonstrated the mean field area percentage of intramural 
trophoblasts within the wall of myometrial spiral arteries to be I 0.15% in the 
normotensive group compared to none in the severe hypertensive group. As expected 
the apoptotic (M30 positive) intramural trophoblast cells in the pre-eclamptic group 
was 0% due to the non-invasion of the artery walls. In contrast to the findings of this 
study, trophoblast apoptosis of spiral arteries has been reported to be similar in 
anemia and normal pregnancies but increased in preeclampsia (Kadyrov et al., 2006). 
This increase of apoptosis of trophoblast cells in the wall of the spiral artery in the 
preeclampsia group is open to speculation. Trophoblastic invasion of spiral arteries 
has being reported to be absent in the majority placental bed biopsies with 
hypertension (Pijnenborg et al., 1991 ). Similarly, Naicker et al (2003) reported a 
total absence of physiological conversion of the myometrial spiral arteries in the 
severe hypertensive disorder of preeclampsia. Both these studies demonstrate an 
absence of trophoblast cells embedded within the vessel wall. The morphometric 
data of elevated apoptosis of intramural trophoblast cells in the pre-eclamptic group 
by Kadyrov et al (2006) may possibly reflect a wide range of inclusion criteria in 
terms of severity of hypertension. Mild hypertension may for example, include a 
range of partial-total physiological conversion. Additionally, others have reported 
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increased apoptosis of syncytiotrophoblasts close to fibrinoid deposition (Nelson, 
1996). The occurrence of M30-positive trophoblasts in the fibrinoid wall of the spiral 
artery of normotensive patients may be allied to the latter report. 
In preeclampsia, the interstitial component of invasion is compromised, with an 
abnormally shallow trophoblast invasion (Brosens et al., I 972). In this study, there 
was a marked elevation of apoptosis of the interstitial trophoblast population in the 
pre-eclamptic group compared to the normotensive group (1.9 % vs 0.8%). Although 
lower in value, the elevation of expression of apoptotis in the preeclamptic group 
conforms to the work carried out by Bulmer et al ( 1988). 
This study further demonstrates variable distribution of anti-M30 immunoexpression 
within giant cells of both study groups. Studies have demonstrated that unlike the 
villous syncytiotrophoblast, these placental bed giant cells express HLA-G class I 
major histocompatibility complex antigens (Loke et al., 1997). The HLA-G on giant 
cells may facilitate interaction with the maternal cells in the placental bed. This 
interaction may lead to some cells undergoing programmed cell death (apoptosis) (AI­
Lamki et al., 1998), while others may undergo terminal differentiation to giant cells. 
DiFederico et al (1999) recently described an absence of apoptosis in normal uterine 
wall with 15-50% of invading cytotrophoblasts in preeclampsia being apoptotic. It is 
unknown whether the increase in the incidence of placental apoptosis seen in 
preeclampsia is a result of the pathologic process leading to or an etiologic 
component in the development of this disorder. Apoptosis is triggered by hypoxia 
(Kerr et al., 1991 ). If a placenta is poorly perfused, it could account for preeclampsia 
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and apoptosis could simply be a marker for hypoxia and not a cause of preeclampsia. 
Similarly, poor placental perfusion and subsequent hypoxia associated with 
preeclampsia could explain the observed increase in interstitial trophoblast apoptosis 
in this study. 
In the normotensive group of this study, dilated spiral artery segments that were 
invaded by trophoblast cells were largely void of macrophages. By contrast, in the 
preeclamptic group, the outer media of undilated spiral artery segments and the 
adventitial boundary were heavily infiltrated by macrophages and devoid of 
extravillous trophoblast. Maternal cells such as macrophages and endothelial cells 
may have a role on trophoblast invasion and apoptosis (Huppertz et al., 2005). In the 
pre-eclamptic group, we observed large numbers of macrophages around most of the 
spiral arterial walls in preeclampsia. It is possible that these cells have a role in 
apoptosis. Reister et al ( 1999; 2001) indicate that macrophages, residing in excess in 
the placental bed of pre-eclamptic women, are able to limit extravillous trophoblast 
invasion of spiral arterial segments through apoptosis mediated by the combination of 
TNFa secretion and tryptophan depletion. The latter study is supported by a report of 
Pijnenborg et al ( 1998), who found a higher incidence of cell clusters secreting TNFct, 
probably macrophages, in the placental bed of patients with severe forms of 
preeclampsia. There are two possible pathways by which macrophages could inhibit 
extravillous trophoblast invasion (a) passively, because apoptotic extravillous 
trophoblast cells may attract macrophages; (b) actively, because macrophages may 
prevent extravillous trophoblast invasion of the vessel walls by inducing apoptosis in 
the perivascular interstitial trophoblast. 
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In conclusion, the immunoexpression pattern of Ki67 antigen in this study suggests 
that differentiation of invasive cytotrophoblast cells in both normal and hypertensive 
pregnancies at term is coordinated with exit from the cell cycle. This study also 
demonstrates that immunoexpression of a neoepitope on cytokeratin 18, recognised 
by the monoclonal antibody M30, is an indicator of apoptosis in epithelial cells. The 
mean field area of the interstitial trophoblast (anti-Ck 18) invasion in the preeclamptic 
group was 2.87 ± 0.5% compared to I 0.79 ± 4.2% in the normotensive group. 
However the serial sections immunostained with CK 18 and its neoepitope-M30 
showed elevation of apoptosis of the invasive interstitial trophoblast cell population 
in the myometrium of the preeclamptic and the normotensive groups respectively 
(J .9 ± 0.5% VS 0.8 ± 0.3%). 
The balance between trophoblast apoptosis and proliferation may represent a 
mechanism to control normal trophoblast invasion. A possibility exists that enhanced 
proliferation precedes apoptosis particularly in early gestation when invasion occurs. 
In a hypoxic environment, trophoblast cells continue to proliferate yet simultaneously 
differentiate abnormally in preeclampsia. In preeclampsia the invasive trophoblast 
cells probably exit the cell cycle in GI phase, directing them towards apoptosis rather 
than passage in the S phase and mitosis. The absence of the compensatory increase in 
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APPENDIX 
1.0 SODIUM CITRATE BUFFER (0.lM; pH 6.0) 
2.94 g Tri-sodium citrate (dihydrate) 
IO00 ml Distilled water 
Mix to dissolve. Adjust pH to 6.0. 
2.0 PHOSPHATE BUFFERED SALINE (PBS) 
I OX PBS (0.1 M PBS, pH 7 .2): 
I 0.9 g Na2HPO4 
3.2 g NaH2PO4 
90 g NaCl 
IO00 ml Distilled water 
Mix to dissolve. 
Dilute I: 10 with distilled water before use and adjust pH if necessary. 
3.0 TRIS BUFFERED SALINE ( I OX) 
82g NaCl 
6.0g Tris Base 
1.0 I dH20 
pH= 7.2-7.4 
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3.1 Tris Buffered Saline-TT 
IX TBS 
0.1 % Triton 
0.1 % Tween 20 
4.0 VON GIESON ELASTIC SOLUTION 
900 ml saturated Picric acid solution 
100 ml I% acid fuchsin dissolved in I/ water. 
Boil for 5 min and filter when cool. 
5.0 MAYER'S HAEMOTOXYLIN 
I g Haemotoxylin 
0.2g Sodium Iodate 
50g Potassium alum 
I g Citric Acid 
50g Choral hydrate 
I 000cm
3 
Dis ti I led water 
Dissolve Haemotoxylin, alum and sodium iodate overnight. Add chloral and citric 
acid and bring to a boil for 5 minutes. Ready to use once cooled. 
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6.0 DAB 
Dissolve DAB plus substrate tablets in 5 ml distilled water. Incubate tissue for 3-10 
min. at room temperature whilst assessing chromagen reaction microscopically. Stop 
reaction by running under tap water. 
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